Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Melanoma × Electrocardiography × Clear all

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Cardiotoxicity 7 Lymphoma, Non-Hodgkin 5 Lymphoma 4 Breast Neoplasms 4 Prostatic Neoplasms 3 Neoplasms 3 Myelodysplastic Syndromes 3 Leukemia 3 Heart Failure 3 Triple Negative Breast Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Multiple Myeloma 2 Lymphoma, B-Cell 2 Lung Neoplasms 2 Leukemia, Myeloid, Acute 2 Hematologic Neoplasms 2 Carcinoma in Situ 2 Burkitt Lymphoma 2 Vulvar Neoplasms 1 Vulvar Diseases 1 Ventricular Dysfunction, Left 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1 Thoracic Neoplasms 1 Stomach Neoplasms 1 Smoking 1 Small Cell Lung Carcinoma 1 Sleep Initiation and Maintenance Disorders 1 Recurrence 1

Interventions

pembrolizumab 268 Nivolumab 241 Ipilimumab 221 aldesleukin 126 Cyclophosphamide 126 Interleukin-2 93 trametinib 76 dabrafenib 68 Dacarbazine 68 Temozolomide 66 fludarabine 64 Vemurafenib 64 fludarabine phosphate 56 Biopsy 45 Radiosurgery 43 sargramostim 40 Bevacizumab 40 binimetinib 39 incomplete Freund's adjuvant 37 Paclitaxel 35 atezolizumab 34 Radiotherapy 34 Cisplatin 34 Blood Specimen Collection 33 encorafenib 32 Magnetic Resonance Spectroscopy 32 cobimetinib 31 Specimen Handling 31 Introns 31 Carboplatin 29

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06605833 2025-10-01

CARD-IO

Royal Marsden NHS Foundation Trust

Enrolling by invitation

Melanoma, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡